Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%
A trial of Pfizer Inc's (PFE.N) experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.
Continue Reading https://www.reuters.com
Join the Discussion